Creative Medical Technology Holdings, Inc. (CELZ) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Creative Medical Technology Holdings, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.78x | -0.62x | -1.23x | -0.41x | 0.30x | -0.22x |
| P/B Ratio | 0.62x | 0.54x | 0.63x | 0.26x | 0.56x | -0.20x |
| P/S Ratio | 778.38x | 310.89x | 721.02x | 47.01x | 65.61x | 48.96x |
| Profitability | ||||||
| Gross Margin | -1992.0% | 60.0% | 60.0% | 67.8% | 45.4% | 69.2% |
| Operating Margin | -102380.2% | -52216.9% | -62445.9% | -11562.5% | -3562.2% | -677.7% |
| Net Margin | -99916.8% | -49940.7% | -58739.7% | -11449.3% | 21892.8% | -22082.2% |
| EBITDA Margin | -100324.8% | -51212.8% | -61395.0% | -11458.6% | 26873.2% | -21294.1% |
| Liquidity | ||||||
| Current Ratio | 25.97x | 18.73x | 27.65x | 5.64x | 10.22x | 0.00x |
| Quick Ratio | 25.97x | 18.72x | 27.64x | 5.64x | 10.21x | 0.00x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -0.02x |
YoY = year-over-year change. Source: FMP..